First Generic Naloxone Nasal Spray Gets FDA Approval
The FDA has granted final approval for the first generic version of Narcan (naloxone hydrochloride nasal spray; Adapt Pharma) to Teva Pharmaceuticals.
More Topics
Endocrine Society Supports European Parliament’s Call for Endocrine-Disrupting Chemical Regulation
The Endocrine Society commended the new resolution from the European Parliament addressing regulation of endocrine-disrupting chemicals.
Elafibranor Gets Breakthrough Therapy Designation for Primary Biliary Cholangitis
The FDA has granted Breakthrough Therapy designation to elafibranor for the treatment of primary biliary cholangitis (PBC) in adults with inadequate response to ursodeoxycholic acid (UDCA).
Clinicians Positioned to Support Partnerships That Address Community Health
Clinicians can promote community investment by helping to create the data and demand that will catalyze efforts to address the root causes of ill health.
CDC Clarifies Guideline on Opioid Prescribing for Chronic Pain
The U.S. Centers for Disease Control and Prevention has clarified that the new guideline on prescribing opioids for chronic pain is not meant to limit access to appropriate pain management.
Patients Develop Inflammatory Arthritis Following Clopidogrel Initiation
A recently published report describes two patient cases involving clopidogrel-induced acute migratory polyarthritis and highlights the importance of timely intervention for this condition.
FDA Warns Against the Use of Unapproved Devices Marketed for Assessing Head Injury
There are a limited number of devices that have been cleared by the FDA for head injury assessment.
Novel Treatment for Neuromyelitis Optica Spectrum Disorder Gets Breakthrough Status From FDA
The FDA has granted Breakthrough Therapy designation to inebilizumab (Viela Bio), an investigational monotherapy for neuromyelitis optica spectrum disorder.
Visit Planning Tools Improve Patients’ Ability to Relay Health Concerns
A waiting room–based health information technology (IT) tool successfully guided patients to start off their primary care visits by communicating their top care priorities.
WHO: Congo Ebola Outbreak Still Not a Global Emergency
The ongoing Ebola outbreak in Congo is of “deep concern” but does not yet qualify as a global emergency.
Sixty People Charged in Massive Opioid Painkiller Investigation
Fifty-three medical professionals, including 31 doctors, are among the 60 people charged by U.S. authorities for their alleged involvement in the illegal prescribing and distribution of opioid painkillers.
CDC: 555 Confirmed Measles Cases in United States Since January 1
The 555 confirmed cases of measles reported in 20 states between Jan. 1 and April 11 this year represent the second highest number of measles cases reported in the United States since measles was eliminated in the nation in 2000.
Residents and Attending Physicians Deliver Nearly Equal Care in VA Clinics
Investigators examined quality of outpatient care with internal medicine resident physicians vs attending physicians in US Department of Veterans Affairs primary care clinics.
New Tool Helps Alert the Public to Unlawfully Marketed Dietary Supplement Ingredients
In an effort to better alert the public of unlawful ingredients in dietary supplements, the FDA has created the Dietary Supplement Ingredient Advisory List, a new reference tool for consumers and manufacturers.
New-Onset Nonischemic Cardiomyopathy Linked to Gabapentin Use
A recently published report describes the case of a patient who developed non-ischemic cardiomyopathy following initiation of gabapentin therapy for pain management.
Peanut Oral Immunotherapy Examined in Real-World Setting
This was the first study to demonstrate the safety of peanut oral immunotherapy among preschool-aged children when administered as routine therapy in a hospital or clinic instead of a clinical trial setting.
Many Pediatric Asthma Cases Attributable to Nitrogen Dioxide Exposure
An estimated 4 million new pediatric asthma cases per year, or 13% of global incidence, may be attributable to ambient nitrogen dioxide exposure.
Terminally Ill People in New Jersey Given Right to End Lives
Terminally ill adults in New Jersey will soon be allowed to seek medical help to end their lives.
ACP Issues Guidance Statement for Breast Cancer Screening in Average-Risk, Asymptomatic Women
The ACP’s guidance statement does not apply to women with prior abnormal screening results or to women with a history of breast cancer or increased risk factors.
Pamrevlumab Gets Orphan Drug Designation for Duchenne Muscular Dystrophy
The Food and Drug Administration (FDA) has granted Orphan Drug designation to pamrevlumab (FibroGen), for the treatment of patients with Duchenne muscular dystrophy (DMD).
Want to read more?
Please login or register first to view this content.
Next post in Tech Talk
